Tech Company Financing Transactions
MLC Dx Funding Round
MLC Dx closed a $5.9 million Series B funding round on 8/13/2010. Investors included Mohr Davidow Ventures and private investors.
Transaction Overview
Company Name
Announced On
8/13/2010
Transaction Type
Venture Equity
Amount
$5,900,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94134
USA
San Francisco, CA 94134
USA
Phone
Email Address
Not Recorded
Overview
The company is developing molecular diagnostic technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Willis
Browse more venture capital transactions:
Prev: 8/13/2010: BringMeTheNews venture capital transaction
Next: 8/13/2010: CeNeRx BioPharma venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs